The world’s largest combined contract research organization (CRO) and biomedical research information services company, IQVIA will form 170 new remote jobs in Ireland as the CRO establishes a COVID-19 vaccine safety monitoring unit in that nation. Targeting professionals with medical information and pharmacovigilance backgrounds, IQVIA offers this solution in conjunction with the commercial launch of the COVID-19 vaccines. Barry Mulchrone, Head of Pharmacovigilance Oversight and Analytics for IQVIA shares the company’s Ireland operation will be “well positioned to play its part in addressing the current global pandemic.”
As reported by Ciara O’Brien with the Irish Times, IQVIA helped pioneer Ireland as a life sciences research hub since its move there in 1990. Leo Varadkar, Ireland’s Minister for Enterprise, Trade and Employment welcomed the news, stating, “IQVIA is doing excellent work on drug safety and I am really pleased to see that they are creating an additional 170 jobs, specifically to prepare for coronavirus vaccines. It is encouraging that these roles will be available to staff working remotely.”
The CRO has commenced recruitment with a target of filling all of the roles before the end of March 2021. Further roles could be added meaning the important COVID-19 research and monitoring activity makes Ireland an important home base.